Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01662713 · ClinicalTrials.gov registry record · NA
Optical Frequency Domain Imaging for Non-melanoma Skin Cancers
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01662713: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01662713 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01662713, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out if a non-invasive imaging device called Optical Frequency Domain Imaging (OFDI) can help doctors to see the tissue and blood vessels that are related to non-melanoma skin cancers. OFDI was designed to see microscopic details of your skin without needing to use any invasive techniques such as surgery or biopsy.
Interventions
- DEVICE OFDI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01662713
The ClinicalTrials.gov registry entry for NCT01662713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OFDI is the first listed.
NCT01662713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01662713 about?
NCT01662713 is a clinical study titled "Optical Frequency Domain Imaging for Non-melanoma Skin Cancers". The purpose of this research study is to find out if a non-invasive imaging device called Optical Frequency Domain Imaging (OFDI) can help doctors to see the tissue and blood vessels that are related to non-melanoma skin cancers. OFDI was designed to see microscopic details of your skin without need...
What is the current status of trial NCT01662713?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-03-01. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT01662713?
The interventions under investigation include: OFDI (DEVICE).
Who is sponsoring clinical trial NCT01662713?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.